Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VIAVI SOLUTIONS INC.VIAV · Entity 3595 | Interim CFO | October 01, 2023 | October 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VIAVI SOLUTIONS INC.
Report date October 01, 2023 · Filed October 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 87,246 |
Reported balance
Holding disclosure · report date 2023-10-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 87,246 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2023-10-01 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F1: Units subject to the Award Shall vest annually in three equal installments over three years. The remaining 3,187 restricted stock units will vest on November 28, 2023. F2: There are no expiration dates on RSUs |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2023-10-01 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F3: Units Subject to the Award shall vest annually in three equal installments over three years. The remaining 4,350 restricted stock units will vest on August 28, 2024. F2: There are no expiration dates on RSUs |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2023-10-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F4: Units subject to the Award shall vest annually in three equal installments over three years. The remaining 9,324 shall vest equally over the next two years on August 28, 2024 and August 28, 2025. F2: There are no expiration dates on RSUs |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2023-10-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance Not disclosed F5: Units subject to the Award shall vest annually in thee equal installments over three years. The restricted stock units were granted on August 28, 2023 and will vest equally on August 28, 2024, August 28, 2025 and August 28, 2026. F2: There are no expiration dates on RSUs |
Filing footnotes · ownership attribution and instrument terms
F1: Units subject to the Award Shall vest annually in three equal installments over three years. The remaining 3,187 restricted stock units will vest on November 28, 2023.
F2: There are no expiration dates on RSUs
F3: Units Subject to the Award shall vest annually in three equal installments over three years. The remaining 4,350 restricted stock units will vest on August 28, 2024.
F4: Units subject to the Award shall vest annually in three equal installments over three years. The remaining 9,324 shall vest equally over the next two years on August 28, 2024 and August 28, 2025.
F5: Units subject to the Award shall vest annually in thee equal installments over three years. The restricted stock units were granted on August 28, 2023 and will vest equally on August 28, 2024, August 28, 2025 and August 28, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2021 Filed Mar 3, 2021 02:15 UTC | VIAVI SOLUTIONS INC. VIAV · Entity 3595 | Exercise / conversionRestricted Stock Units · Derivative | 3,392 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000912093-21-000047 · wf-form4_161473771933902.xml · derivative · entry 3 Avent Pamela K. · CIK 0001832901 · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,484 Underlying: Common Stock · 3,392 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each unit converts upon vesting into one share of common stock. F4 · derivative.exercise_date: 1/3 of the Units subject to the Award shall vest on the first anniversary of the grant date and the remaining shares vest quarterly in eight equal installments over the following two years. F5 · derivative.expiration_date: There are no expiration dates on RSUs. Read SEC document |
| February 28, 2021 Filed Mar 3, 2021 02:15 UTC | VIAVI SOLUTIONS INC. VIAV · Entity 3595 | Tax withholdingCommon Stock | 1,395 | $16.19 | $22,585.05 |
DisclosureSEC source: 0000912093-21-000047 · wf-form4_161473771933902.xml · nonDerivative · entry 2 Avent Pamela K. · CIK 0001832901 · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,452 F3 · kind: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| February 28, 2021 Filed Mar 3, 2021 02:15 UTC | VIAVI SOLUTIONS INC. VIAV · Entity 3595 | Exercise / conversionCommon Stock | 3,392 | $0.00 | $0.00 |
DisclosureSEC source: 0000912093-21-000047 · wf-form4_161473771933902.xml · nonDerivative · entry 1 Avent Pamela K. · CIK 0001832901 · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each unit converts upon vesting into one share of common stock. F2 · balance_after: Total includes 1,574 shares purchased pursuant to the ESPP plan. Read SEC document |
| November 28, 2020 Filed Dec 2, 2020 00:40 UTC | VIAVI SOLUTIONS INC. VIAV · Entity 3595 | GrantRestricted Stock Units · Derivative | 9,561 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000912093-20-000122 · wf-form4_160686963470399.xml · derivative · entry 5 Avent Pamela K. · CIK 0001832901 · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,561 Underlying: Common Stock · 9,561 shares Expires not disclosed F4 · derivative.exercise_date: Units subject to the Award shall vest annually in three equal installments over three years. F3 · derivative.expiration_date: There are no expiration dates on RSUs. Read SEC document |
| November 28, 2020 Filed Dec 2, 2020 00:40 UTC | VIAVI SOLUTIONS INC. VIAV · Entity 3595 | Exercise / conversionRestricted Stock Units · Derivative | 1,675 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000912093-20-000122 · wf-form4_160686963470399.xml · derivative · entry 4 Avent Pamela K. · CIK 0001832901 · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,725 Underlying: Common Stock · 1,675 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each unit converts upon vesting into one share of common stock. F3 · derivative.expiration_date: There are no expiration dates on RSUs. Read SEC document |
| November 28, 2020 Filed Dec 2, 2020 00:40 UTC | VIAVI SOLUTIONS INC. VIAV · Entity 3595 | Exercise / conversionRestricted Stock Units · Derivative | 1,717 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000912093-20-000122 · wf-form4_160686963470399.xml · derivative · entry 3 Avent Pamela K. · CIK 0001832901 · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,151 Underlying: Common Stock · 1,717 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each unit converts upon vesting into one share of common stock. F3 · derivative.expiration_date: There are no expiration dates on RSUs. Read SEC document |
| November 28, 2020 Filed Dec 2, 2020 00:40 UTC | VIAVI SOLUTIONS INC. VIAV · Entity 3595 | Tax withholdingCommon Stock | 1,174 | $13.96 | $16,389.04 |
DisclosureSEC source: 0000912093-20-000122 · wf-form4_160686963470399.xml · nonDerivative · entry 2 Avent Pamela K. · CIK 0001832901 · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,881 F2 · kind: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| November 28, 2020 Filed Dec 2, 2020 00:40 UTC | VIAVI SOLUTIONS INC. VIAV · Entity 3595 | Exercise / conversionCommon Stock | 3,392 | $0.00 | $0.00 |
DisclosureSEC source: 0000912093-20-000122 · wf-form4_160686963470399.xml · nonDerivative · entry 1 Avent Pamela K. · CIK 0001832901 · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each unit converts upon vesting into one share of common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.